The Miracle of Hemp Cannabinoids
Index of Sciences Ltd. Kemp House, 160 City Road, London. www.indexofsciences.com (Independently published), London, 2024
- Yayın Türü: Kitap / Mesleki Kitap
- Basım Tarihi: 2024
- Yayınevi: Index of Sciences Ltd. Kemp House, 160 City Road, London. www.indexofsciences.com (Independently published)
- Basıldığı Şehir: London
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
The Miracle of Hemp: Cannabinoids, by Prof. Dr. Ahmet Karadağ, provides a multidisciplinary overview of the chemical characteristics, biological activities, and therapeutic potential of cannabinoids. Across ten chapters, the book connects cannabinoid chemistry with pharmacology, biochemistry, and research in diverse medical fields. It introduces readers to the scientific foundations of cannabinoid activity while examining possible applications, limitations, and safety considerations.
The opening chapters establish the chemical and biological framework for understanding cannabinoids, with particular attention to cannabidiol (CBD), delta-9-tetrahydrocannabinol (Δ⁹-THC), endogenous cannabinoids, and synthetic compounds. The endocannabinoid system, including CB1 and CB2 receptors, provides a central explanatory framework for their effects on neural signaling, immune responses, inflammation, and physiological regulation. Differences in pharmacological activity, mechanisms of action, and pharmacokinetic behavior are discussed alongside the historical development and legal context of cannabis use.
A major theme is the investigation of cannabinoids as antimicrobial, anti-inflammatory, and anticancer agents. The book reviews research on antibacterial and antifungal activity, including studies involving resistant microorganisms and combinations with conventional antibiotics. Its discussion of cancer addresses mechanisms associated with the inhibition of cell proliferation, apoptosis, autophagy, and modulation of cellular signaling. Potential roles in combination therapy and supportive cancer care are also considered, including the management of pain, nausea, and appetite-related symptoms. These discussions identify promising research directions while acknowledging the need for further mechanistic investigation and clinical validation.
Neurological and psychiatric applications constitute another substantial focus. The book explores endocannabinoid signaling in brain function and its relevance to epilepsy, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, schizophrenia, anxiety, depression, and substance use. A dedicated chapter examines chronic pain, particularly neuropathic pain and migraine, linking the biological regulation of pain to findings from experimental and clinical studies. Pharmaceutical preparations and therapeutic applications are discussed in relation to formulation quality, administration, efficacy, and adverse effects.
The scope extends to oral and dental health, ear, nose, and throat conditions, infectious diseases, and dermatology. Topics include periodontal inflammation, oral pain, dental microbial populations, oral cancer, and selected ear and nasal disorders. The book also examines research concerning cannabinoids in viral infections, including HIV and COVID-19, with attention to immune modulation and inflammatory responses. Dermatological discussions address acne, pruritus, and other inflammatory skin conditions, highlighting the relevance of cannabinoid signaling to skin homeostasis.
The final chapters broaden the discussion to endothelial and tissue functions and applications in internal medicine. They consider intestinal permeability, hepatic metabolism, cardiovascular health, gastrointestinal disorders, autoimmune and musculoskeletal diseases, sleep disturbances, and anorexia/cachexia. Across these areas, the book presents cannabinoids as a chemically diverse group whose biological effects depend on the compound, target, and disease context. Supported by references, tables, and illustrations, it offers students, academics, and researchers an accessible resource connecting molecular mechanisms with therapeutic investigation. Its overall contribution is to bring together a broad body of cannabinoid research while drawing attention to the importance of standardized preparations, safety assessment, and stronger clinical evidence.